{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:41:22Z","timestamp":1722991282018},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66301","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:23:41Z","timestamp":1722965021000},"source":"Crossref","is-referenced-by-count":0,"title":["Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine Among Family Medicine Residents in Riyadh, Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Raed","family":"Alahmari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah I","family":"Altashlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz A","family":"Alsheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Aljaloud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Herpes Zoster","author":"Nair PA","year":"2024","unstructured":"Nair PA, Patel BC. Herpes Zoster. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","unstructured":"Clinical overview of herpes zoster (shingles). (2024). Accessed. June 6, 2024: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S361320","article-title":"HIV\/AIDS associated lymphoma: review","volume":"12","author":"Berhan A","year":"2022","unstructured":"Berhan A, Bayleyegn B, Getaneh Z. HIV\/AIDS associated lymphoma: review. Blood Lymphat Cancer. 2022, 12:31-45. 10.2147\/BLCTT.S361320","journal-title":"Blood Lymphat Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/25151355221084535","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","author":"Pan CX","year":"2022","unstructured":"Pan CX, Lee MS, Nambudiri VE. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Ther Adv Vaccines Immunother. 2022, 10:25151355221084535. 10.1177\/25151355221084535","journal-title":"Ther Adv Vaccines Immunother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0180-7","article-title":"Shingles (herpes zoster) vaccine (Zostavax(\u00ae)): a review in the prevention of herpes zoster and postherpetic neuralgia","volume":"30","author":"Keating GM","year":"2016","unstructured":"Keating GM. Shingles (herpes zoster) vaccine (Zostavax(\u00ae)): a review in the prevention of herpes zoster and postherpetic neuralgia. BioDrugs. 2016, 30:243-54. 10.1007\/s40259-016-0180-7","journal-title":"BioDrugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar P","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009, 84:274-80. 10.4065\/84.3.274","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33508","article-title":"A cross-sectional study of the knowledge, practice, and attitude towards herpes zoster vaccination among the general population in the western region of Saudi Arabia","volume":"15","author":"Alhothali OS","year":"2023","unstructured":"Alhothali OS, Alhothali AS, Hanif AA, Bondagji MF, Aljabri HM, Goweda R. A cross-sectional study of the knowledge, practice, and attitude towards herpes zoster vaccination among the general population in the western region of Saudi Arabia. Cureus. 2023, 15:e33508. 10.7759\/cureus.33508","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2073752","article-title":"Knowledge, attitudes, and practices of the United Arab Emirates population towards herpes zoster vaccination: a cross-sectional study","volume":"18","author":"Al-Khalidi T","year":"2022","unstructured":"Al-Khalidi T, Genidy R, Almutawa M, et al.. Knowledge, attitudes, and practices of the United Arab Emirates population towards herpes zoster vaccination: a cross-sectional study. Hum Vaccin Immunother. 2022, 18:2073752. 10.1080\/21645515.2022.2073752","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2167907","article-title":"Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer","volume":"19","author":"Curran D","year":"2023","unstructured":"Curran D, Patterson BJ, Carrico J, et al.. Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Hum Vaccin Immunother. 2023, 19:2167907. 10.1080\/21645515.2023.2167907","journal-title":"Hum Vaccin Immunother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49396","article-title":"Public knowledge, attitude, and practice toward herpes zoster vaccination in Saudi Arabia","volume":"15","author":"Alleft LA","year":"2023","unstructured":"Alleft LA, Alhosaini LS, Almutlaq HM, Alshayea YM, Alshammari SH, Aldosari MA, Alateeq FA. Public knowledge, attitude, and practice toward herpes zoster vaccination in Saudi Arabia. Cureus. 2023, 15:e49396. 10.7759\/cureus.49396","journal-title":"Cureus"},{"key":"ref11","article-title":"Chapter 13: methods for survey studies","author":"Lau F","year":"2017","unstructured":"Lau F. Chapter 13: methods for survey studies. Handbook of eHealth Evaluation: An Evidence-based Approach. University of Victoria, Canada; 2017."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1086-5802(16)31204-9","article-title":"People vaccinated by pharmacists: descriptive epidemiology","volume":"41","author":"Grabenstein JD","year":"2001","unstructured":"Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by pharmacists: descriptive epidemiology. J Am Pharmaceut Assoc. 2001, 41:46-52. 10.1016\/s1086-5802(16)31204-9","journal-title":"J Am Pharmaceut Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.037","article-title":"Demographic characteristics of members of the Vaccine Safety Datalink (VSD): a comparison with the United States population","volume":"33","author":"Sukumaran L","year":"2015","unstructured":"Sukumaran L, McCarthy NL, Li R, et al.. Demographic characteristics of members of the Vaccine Safety Datalink (VSD): a comparison with the United States population. Vaccine. 2015, 33:4446-50. 10.1016\/j.vaccine.2015.07.037","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.041","article-title":"Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument","volume":"37","author":"Luyten J","year":"2019","unstructured":"Luyten J, Bruyneel L, van Hoek AJ. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Vaccine. 2019, 37:2494-501. 10.1016\/j.vaccine.2019.03.041","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2018.02.002","article-title":"Adequacy of information provided by healthcare professionals on vaccines: results of a population survey in Spain","volume":"101","author":"Esteban-Vasallo MD","year":"2018","unstructured":"Esteban-Vasallo MD, L\u00f3pez de Andr\u00e9s A, Bay\u00f3n M, Ar\u00e9jula JL, Jim\u00e9nez-Garc\u00eda R. Adequacy of information provided by healthcare professionals on vaccines: results of a population survey in Spain. Patient Educ Couns. 2018, 101:1240-7. 10.1016\/j.pec.2018.02.002","journal-title":"Patient Educ Couns"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00012-8","article-title":"COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics","volume":"6","author":"Schwarzinger M","year":"2021","unstructured":"Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021, 6:e210-21. 10.1016\/S2468-2667(21)00012-8","journal-title":"Lancet Public Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.793533","article-title":"Influence of vaccination characteristics on COVID-19 vaccine acceptance among working-age people in Hong Kong, China: a discrete choice experiment","volume":"9","author":"Wang K","year":"2021","unstructured":"Wang K, Wong EL, Cheung AW, et al.. Influence of vaccination characteristics on COVID-19 vaccine acceptance among working-age people in Hong Kong, China: a discrete choice experiment. Front Public Health. 2021, 9:793533. 10.3389\/fpubh.2021.793533","journal-title":"Front Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.756037","article-title":"Socio-demographic factors associated with COVID-19 vaccine hesitancy among middle-aged adults during the Quebec\u2019s vaccination campaign","volume":"10","author":"Jantzen R","year":"2022","unstructured":"Jantzen R, Maltais M, Bro\u00ebt P. Socio-demographic factors associated with COVID-19 vaccine hesitancy among middle-aged adults during the Quebec\u2019s vaccination campaign. Front Public Health. 2022, 10:756037. 10.3389\/fpubh.2022.756037","journal-title":"Front Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15081743","article-title":"Willingness to participate in vaccine-related clinical trials among older adults","volume":"15","author":"Raheja D","year":"2018","unstructured":"Raheja D, Davila EP, Johnson ET, Deovi\u0107 R, Paine M, Rouphael N. Willingness to participate in vaccine-related clinical trials among older adults. Int J Environ Res Public Health. 2018, 15:1743. 10.3390\/ijerph15081743","journal-title":"Int J Environ Res Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp365","article-title":"Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization","volume":"171","author":"Chao C","year":"2010","unstructured":"Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010, 171:357-67. 10.1093\/aje\/kwp365","journal-title":"Am J Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276478-practices-attitudes-and-knowledge-regarding-recombinant-zoster-vaccine-among-family-medicine-residents-in-riyadh-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:23:44Z","timestamp":1722965024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276478-practices-attitudes-and-knowledge-regarding-recombinant-zoster-vaccine-among-family-medicine-residents-in-riyadh-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66301","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}